← Back to Engines
Enterprise Value Engine

EBITDA Enhancement

Enterprise value optimization through healthcare cost reduction with PE-grade financial modeling for EBITDA impact quantification.

$4.2M
Avg Value Creation
6-9x
EBITDA Multiple
18mo
Implementation
Board-Ready
Reporting

The $4M EBITDA Hole No One Sees

PE Operators Miss Healthcare's EBITDA Contribution

Healthcare benefits are the #2 or #3 expense line for most portfolio companies, yet PE operators treat it as an HR administrative function, not an EBITDA optimization opportunity. The result: $2M-$8M in annual EBITDA leakage goes unaddressed because it's buried in "employee benefits" — invisible to the deal team and operating partners.

A typical $100M revenue manufacturing company with 500 employees has $4M-$6M in addressable healthcare waste. That's 4-6% EBITDA margin expansion — the difference between a 2.5x and 3.2x exit multiple.

Without This Engine

  • ×Healthcare buried in G&A — no visibility to deal team
  • ×Operating partners lack healthcare domain expertise to challenge brokers
  • ×Broker incumbency bias: "market is up 12%, nothing we can do"
  • ×No EBITDA attribution for healthcare spend reduction
  • ×Exit valuation leaves $10M-$30M on table (4-6% margin × enterprise value multiple)

With This Engine

  • 100-day forensic audit identifying $2M-$8M in addressable leakage
  • EBITDA-attributed savings roadmap (Yr 1: $1.8M, Yr 2: $2.4M, Yr 3: $3.1M)
  • Quantified implementation risk and timeline for each initiative
  • Board-ready business case with ROI, payback period, and sensitivities
  • Continuous monitoring dashboard linking initiatives to EBITDA impact

Five-Pillar Forensic Framework

Audit Depth
18 vectors
Cost leakage pathways
Data Volume
36 months
Claims + contract history
Analysis Time
5-7 days
Full forensic completion
Avg. Finding
$2.4M
Annual addressable waste

Five Forensic Pillars

Pillar 1: PBM Contract Leakage

30-40% OF EBITDA OPPORTUNITY

Analyze Rx claims against PBM contract guarantees. Detect spread pricing (ingredient cost + dispensing fee vs. MAC list), rebate underperformance (contractual rebate % vs. actual remittance), formulary misalignment (brand Rxs where generic equivalents exist), and hidden fees (DIR clawbacks, annual administrative fees not disclosed at RFP).

# Spread Detection Algorithm
For each Rx claim:
  Contract_MAC = lookup(NDC, contract_MAC_list)
  Actual_Paid = ingredient_cost + dispensing_fee
  Spread = Actual_Paid - Contract_MAC
  
Annual_Leakage = Sum(Spread × Scripts)

Example Finding:
  500K scripts/year
  Average spread: $4.80/script
  Annual leakage: $2.4M → flows to EBITDA if recovered

Typical Culprits:
- Specialty pharmacy spread ($15-$40/script)
- Brand-generic substitution failures ($180/script)
- DIR fee clawbacks (3-5% of ingredient cost)
- Administrative fees exceeding contract caps

Pillar 2: Stop-Loss Insurance Optimization

15-25% OF EBITDA OPPORTUNITY

Model optimal specific and aggregate deductibles based on actual large claimant distribution. Most companies over-insure (paying too much premium for coverage they'll never use) or under-insure (exposing balance sheet to tail risk). Right-sizing stop-loss saves $300K-$900K annually for a 500-life group.

# Monte Carlo Stop-Loss Optimization
For each deductible level ($200K, $250K, $300K, $350K):
  Run 10,000 simulations:
    - Draw large claims from historical distribution
    - Calculate net cost = Premium + Claims_Above_Deductible
  
  Expected_Cost[deductible] = Mean(net_cost)
  95th_Percentile_Cost[deductible] = P95(net_cost)

Optimal_Deductible = Min(Expected_Cost) subject to:
  95th_Percentile < Risk_Tolerance_Threshold

Example Result:
  Current: $200K deductible, $1.2M premium
  Optimal: $300K deductible, $850K premium
  EBITDA Impact: $350K annual savings
  Risk: 95th percentile cost increases $180K (acceptable)

Pillar 3: Medical Network Performance

20-30% OF EBITDA OPPORTUNITY

Compare actual allowed amounts vs. Medicare rates by procedure code and facility. Identify high-cost outliers (hospitals charging 400% of Medicare for the same procedure as a lower-cost alternative 5 miles away). Site-of-care migration (inpatient → outpatient, hospital → ASC) and reference-based pricing strategies.

# Unit Cost Benchmarking
For each CPT code:
  Allowed_Amount = What_Plan_Paid
  Medicare_Rate = CMS_Fee_Schedule[CPT, Locality]
  Benchmark_Ratio = Allowed_Amount / Medicare_Rate

High_Cost_Procedures = filter(Benchmark_Ratio > 250%)

Savings_Opportunity = Sum(
  (Allowed - Medicare × 180%) × Claim_Volume
) for High_Cost_Procedures

Example Finding:
  Knee MRI at Hospital A: $2,800 (450% of Medicare)
  Knee MRI at Imaging Center B: $850 (140% of Medicare)
  Volume: 120 MRIs/year
  Savings: $234K if steered to Center B
  Implementation: benefit design (lower copay at preferred sites)

Pillar 4: Plan Design & Cost Sharing

10-15% OF EBITDA OPPORTUNITY

Model employee cost-sharing strategies that reduce total cost while maintaining workforce satisfaction. High-deductible plans with HSA contributions, narrow networks, tiered copays for specialty drugs, and prior authorization for high-cost imaging reduce utilization by 8-15% with minimal employee pushback when implemented correctly.

# Cost-Sharing Elasticity Model
For each plan design change:
  Utilization_Impact = Demand_Elasticity × Cost_Share_Change
  Employee_Premium_Change = Pass_Through_Rate × Total_Cost_Change
  
  Total_Savings = (Utilization_Impact + Plan_Premium_Impact) - Employee_Pushback_Cost

Example Scenario:
  Change: Increase ER copay $100 → $250
  Elasticity: -0.15 (15% reduction per 100% cost increase)
  ER visits: 180/year @ $2,400 average
  Utilization drop: 27 visits (15% × 180)
  Gross savings: $64,800 (27 × $2,400)
  Employee premium reduction: $32/month (share 50% of savings)
  Net EBITDA impact: +$45K/year

Pillar 5: Payment Integrity & Recovery

5-10% OF EBITDA OPPORTUNITY

Detect duplicate payments, upcoding, unbundling, and medical necessity violations in paid claims. Deploy automated prepayment edits for high-risk claim patterns. Typical recovery: 2-4% of annual medical spend, of which 50-70% is net-new EBITDA (the rest offsets future claims).

# Payment Integrity Rules Engine
Rule Set:
1. Duplicate Claim Detection
   - Same member, CPT, date, provider within 24 hours
   
2. Unbundling Detection
   - Multiple line items that should be single procedure code
   - Example: Colonoscopy + biopsy billed separately (should be bundled)
   
3. Upcoding Detection
   - Office visit coded as Level 5 (99215) when documentation supports Level 3
   
4. Medical Necessity
   - MRI ordered without prior conservative treatment
   - Brand drug prescribed when generic clinically equivalent

Annual Recovery Example:
  Medical spend: $12M
  Claims flagged: 340 (2.8% of volume)
  Overpayment identified: $420K (3.5% of spend)
  Net recovery after appeals: $294K (70% success rate)
  → Direct EBITDA lift

EBITDA Attribution & Tracking

Every initiative is mapped to EBITDA impact with implementation timeline, success probability, and ongoing monitoring KPIs. This enables PE operators to include healthcare optimization in their investment thesis and track it alongside other margin expansion initiatives.

3-Year EBITDA Roadmap Example

Portfolio Company: Manufacturing, 500 employees, $100M revenue, $12M EBITDA
Current Healthcare Spend: $6.2M (5.0% of payroll)

Year 1 Initiatives (100-Day Plan)
├─ PBM Contract Renegotiation: $850K (Q2 implementation)
├─ Stop-Loss Optimization: $320K (Q1 implementation)
├─ Payment Integrity Launch: $180K (Q3 recovered claims)
└─ Plan Design Adjustment: $220K (Q4 open enrollment)
   TOTAL YEAR 1: $1.57M → 13.1% EBITDA growth

Year 2 Initiatives
├─ Reference-Based Pricing (Phase 1): $420K
├─ Specialty Pharmacy Carve-Out: $380K
├─ Site-of-Care Steering: $290K
└─ Ongoing Payment Integrity: $240K
   TOTAL YEAR 2: $1.33M → cumulative $2.90M

Year 3 Initiatives
├─ Direct Contracting (Musculoskeletal): $510K
├─ GLP-1 Management Program: $280K (cost avoidance)
├─ Network Optimization (ACO partnership): $340K
└─ Ongoing Programs: $380K
   TOTAL YEAR 3: $1.51M → cumulative $4.41M

Exit Impact:
  EBITDA improvement: $4.41M annually (36.8% increase)
  At 6.5x EBITDA multiple: +$28.7M enterprise value
  Investment: $420K consulting + implementation
  ROI: 68x

Initiative Tracking

Each initiative has defined owner, timeline, success metrics, and EBITDA attribution model

Monthly EBITDA Reconciliation

Actual savings vs. projected, variance analysis, and course corrections

Portfolio Benchmarking

Compare healthcare cost performance across portfolio companies, identify laggards

Portfolio Company Case Studies

Manufacturing PortCo
$3.8M EBITDA

Mid-market bolt-and-fastener manufacturer with 420 employees. PBM contract forensics revealed $1.2M annual spread pricing, stop-loss reoptimization saved $380K, site-of-care program delivered $420K. Combined with network renegotiation: $3.8M recurring EBITDA improvement over 18 months. Exit multiple increased from 5.8x to 6.4x.

Healthcare Services Platform
$6.2M EBITDA

Roll-up of 8 behavioral health clinics, 850 employees. Harmonized benefits across entities while reducing total cost. Self-funded captive with reference-based pricing for hospital claims. Specialty pharmacy carve-out with transparent PBM. Payment integrity program recovering $340K annually. Total: $6.2M EBITDA improvement, 19% margin expansion.

PE Thesis Validation
$2.1M at LOI

Pre-acquisition forensic audit identified $2.1M in addressable healthcare waste. PE firm built this into acquisition model as Year 1 margin expansion initiative. Engine findings supported valuation bridge, identified implementation risks, and provided 100-day roadmap. Actual Year 1 delivery: $1.9M (90% of projected).

How Much EBITDA Are You Leaving on the Table?

Run a 100-day forensic audit on your portfolio company. Quantify addressable healthcare waste, build an EBITDA-attributed roadmap, and start flowing savings to the bottom line in 90 days.

Request Forensic Audit→